Melvin Booth

Melvin Booth
Chairman of the Board

Melvin Booth, Chairman of the Board

Mr. Booth has been chairman of the board and a director since June 2013. He is also a member of Mallinckrodt’s Audit and Portfolio committees.

Mr. Booth has been a director of Catalent Pharma Solutions since 2010 and chairman of the board and a director of eResearchTechnology, Inc. since 2012. He has also been a strategic advisor in life sciences to Genstar Capital, a private equity firm, since 2005.

Mr. Booth’s previous public company board experience includes serving as lead director of Millipore Corporation from 2004 to 2010 and as a director of MedImmune from 1998 to 2005. He was also president of MedImmune from 1998 until his retirement at the end of 2003. Mr. Booth was chairman of the board and a director of PRA International from 2004 to 2013. He was president and a director of Human Genome Sciences from 1995 to 1998. Mr. Booth held a variety of domestic and international positions with Syntex from 1981 to 1995, including serving as president of its U.S. pharmaceuticals business. He has also been active in U.S. pharmaceutical industry organizations and is a past chairman of the Pharmaceutical Manufacturers Association of Canada.

Mr. Booth received a bachelor’s degree in accounting from Northwest Missouri State University in Maryville, Mo., where he was also awarded an honorary Doctor of Science degree. He is also a certified public accountant.